Hold Parameters on Likely Cardiovascular Depressant Medications
NCT00527709 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2020-08-05
Summary
This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient.
There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.
Research Question:
Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?
Conditions
- Asystole
- Bradycardia
- Hypotension
Sponsors & Collaborators
-
Hackensack Meridian Health
lead OTHER
Principal Investigators
-
Amit Tailor, MD, MBA · Hackensack Meridian Health
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2006-08-31
- Completion
- 2006-08-31
Countries
- United States
Study Locations
More Related Trials
-
Local Vasoconstriction in Postural Tachycardia Syndrome
NCT01210430 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
NCT01000350 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride
NCT00426842 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
NCT01056718 ·Status: COMPLETED ·Phase: NA
-
Autonomic Phenotype Before and After Akt Inhibition
NCT01593579 ·Status: WITHDRAWN
-
The Pathophysiology of Orthostatic Hypotension
NCT00748059 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
NCT00004268 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
NCT05168462 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
NCT04620382 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
NCT02726711 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure
NCT01971944 ·Status: COMPLETED
-
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
NCT00401882 ·Status: TERMINATED ·Phase: PHASE2
-
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
NCT02429557 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
NCT00555880 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome
NCT03182725 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of Atropine and Propranolol Induced Changes
NCT00251602 ·Status: COMPLETED ·Phase: PHASE1
-
Water and Sudafed in Autonomic Failure
NCT02149901 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
A Novel Device for the Treatment of Postural Hypotension - a Signal of Effectiveness Study.
NCT06039410 ·Status: RECRUITING ·Phase: NA
-
Cardiovascular Effects of Selective I(f)-Channel Blockade
NCT00865917 ·Status: UNKNOWN ·Phase: PHASE2
-
NT-proBNP in Acute Dyspnea: Effects on Treatment, Hospitalisation and Costs
NCT00410293 ·Status: COMPLETED ·Phase: NA
-
A Study in Subjects With Neurogenic Orthostatic Hypotension
NCT07089043 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Cardiac Sympathetic Blockade in Patients With Chronic Heart Failure
NCT02282618 ·Status: UNKNOWN
-
POTS NET mRNA Functional Correlation With NET Activity
NCT03218761 ·Status: ACTIVE_NOT_RECRUITING
-
Droperidol and QTc Interval Changes in ED Patients
NCT06726811 ·Status: RECRUITING
-
Clinical Trial for the Prevention of Vasovagal Syncope
NCT00118482 ·Status: COMPLETED ·Phase: PHASE4